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In adriamycin nephropathy (AN), a model of chronic
proteinuric renal injury, the absence of functional B and T
cells with residual natural killer (NK) cells, and macrophages
in severe combined immunodeficient (SCID) mice results in
more severe disease than in immunocompetent mice. We
have recently shown expression of the stimulatory NK cell
molecule NKG2D and its ligand RAE-1 in the adriamycin
(ADR) kidney. Therefore, we sought to determine the role of
NK cells in AN. We used anti-asialo GM1 NK cell depletion in
immunocompetent BALB/c mice with AN, and also compared
AN in immunodeficient SCID mice and immunodeficient
nonobese diabetic (NOD)-SCID mice (that have impaired NK
cell function). The number of NK cells was increased in AN in
BALB/c mice compared with normal controls. NK cell
depletion or reduction of NK function in NOD-SCID mice did
not affect the severity of disease. In both wild type and
immunodeficient models, ADR upregulated RAE-1 in the
kidney. High levels of Class I major histocompatibility
complex molecules were found in both models of AN. In
conclusion, NK cells do not play a significant role in AN.
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Adriamycin (ADR)-induced nephropathy is a robust model
of human focal segmental glomerulosclerosis.1,2 The severity
of renal damage and dysfunction in human renal disease and
animal models correlates with the degree of interstitial
infiltration by inflammatory cells, predominantly T lympho-
cytes and macrophages.3–5 Previous studies in our laboratory
showed that depletion of CD8þ T cells protects while
depletion of CD4þ T cells aggravates adriamycin nephro-
pathy (AN) in BALB/c mice.6,7 However, the role of other
effector cells such as natural killer (NK) cells is unknown. The
greater sensitivity of the severe combined immunodeficient
(SCID) mouse to ADR, where NK cells are the predominant
immune effector cell besides macrophages, suggests either
that the cognate immune cells provide protection from injury
as suggested by our CD4 depletion data or that the NK
population together with macrophages in these mice
exacerbates the renal injury. In glomerulonephritis, a possible
involvement of NK cells was suggested by finding that local
production of fractalkine and the presence of CD16-positive
cells, which include NK cells, in the interstitial lesions of
human crescentic glomerulonephritis.8 However, evidence
for cytotoxic injury by NK cell was not found in rat
antiglomerular membrane glomerulonephritis9 and cell-
mediated glomerulonephritis.10
NK cells, a pivotal component of the innate immune
system, are derived from haematopoietic stem cells, which
have been identified in sites such as bone marrow, thymus,
spleen, omentum, and liver in adults.11 Under normal
conditions, NK cells are mostly confined to peripheral blood,
spleen, and bone marrow, but they can migrate to inflamed
tissues in response to different chemoattractants.12 NK cells
recognize other cells which lack major histocompatibility
complex (MHC) Class I expression via ‘the missing self
hypothesis’ using a variety of inhibitory receptors that bind
to Class I molecules; this leads to NK responses to both
tumors and virally infected cells that downregulate their Class
I expression.13 NK cells release both inflammatory cytokines
and cytotoxic molecules including perforin, granzyme, and
tumor necrosis factor-related apoptosis-inducing ligand
causing rapid injury to tissues not recognized as self.14 More
recently, molecules that function as activating receptors have
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been described on NK cells. Specifically, NKG2D binds to a
co-receptor DAP12 on the NK cell and is activated by a range
of Class Ib MHC molecules including RAE-1 and H-60 in
mice and MICA in humans that are upregulated by stress or
danger. It is unclear whether the activating signal received
through these interactions can override the inhibitory signals
generated by inhibitory receptors interacting with Class I
MHC molecules. The crucial importance of this pathway is
demonstrated by its preservation across species and the use of
molecular homologues of ligands by viruses to avoid killing.
In order to test the role of NK cells we have used two
approaches. We first performed NK cell depletion in the
standard model of AN using an antibody to glycolipid asialo
GM1 or ganglio-n-tetraosylceramide.15 This has been shown
to be effective for NK depletion in tumor and transplantation
animal models.16–18 Secondly, we examined NK cell effects in
isolation by comparing AN in the SCID and nonobese
diabetic (NOD)-SCID mouse. The severity of AN was
assessed in both the antibody depletion model and in
immunodeficient NOD-SCID mice, where the NK cells are
present but functionally inactive. We also measured expres-
sion of NK cell activating ligand RAE-1 and inhibitory ligand
H-2kd and the presence of the activating receptor NKG2D.
RESULTS
NK cell depletion
Repeated injections of anti-asialo GM1 serum significantly
depleted NK cells in kidney as well as spleen in BALB/c mice
with AN (Figures 1–3). Renal NK cells appeared to be more
numerous in BALB/c mice with AN than controls, but
the difference was not significant when assessed by fluores-
cence-activated cell scan (FACScan) (0.5270.18 versus
0.3070.14%, P¼ 0.11). However, the number of NK cells
in kidney, estimated by multiplying total number of
interstitial CD45þ cells isolated by the percentage of NK
cells within the CD45þ population, was significantly higher
in AN BALB/c mice than in normal control (13 53472984
versus 346071937, Po0.05) (Figure 1e). Anti-asialo GM1
serum significantly depleted NK cells from kidney of mice
with AN (0.2170.08 versus 0.5270.18% by FACScan,
Po0.01, 13 53472984 versus 381971081 in total number
of NK cells per kidney, Po0.05) (Figure 1). Anti-asialo GM1
serum also depleted NK cells in spleen of mice with AN
(4.2870.67 versus 10.9371.09% by FACScan, Po0.01)
(Figures 2 and 3).
Renal functional injury
As expected, mice with AN had significantly worse renal
function at 5 weeks than control, as assessed by urine protein
(3.8870.72 versus 1.0570.27 mg/16 h, Po0.05) and creati-
nine clearance (21.779.1 versus 42.2715.9 ml/min, Po0.05).
Anti-asialo GM1 depletion of NK cells had no effect on any
renal function parameter in mice with AN (Table 1).
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Figure 1 | NK cell depletion assessed by flow cytometry of kidney
infiltrating NK cells. (a–c) Representative histograms of kidney
infiltrating NK cells. (d) Percentage of NK cells in CD45þ gated
population. (a) Normal BALB/c mice (n¼ 4), (b) AN mice (n¼ 5), and
(c) AN mice with NK cells depleted by GM1 (n¼ 5). (e) Total number
of NK cells per kidney estimated by multiplying total number of
interstitial CD45þ cells isolated per kidney by the percentage of NK
cells within the CD45þ population. *Po0.05 versus ADR (analysis of
variance).
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Figure 2 | NK cell depletion assessed by flow cytometry of splenic
NK cells. (a–c) Representative histograms of splenic NK cells.
(d) Percentage of NK cells in CD45þ gated population. (a) Normal
BALB/c mice (n¼ 4), (b) AN mice (n¼ 5), and (c) AN mice with NK
cells depleted by GM1 (n¼ 5). **Po0.01 versus normal and ADR
(analysis of variance).
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Figure 3 | (a–c) NK cell depletion assessed by immunohisto-
chemical staining for NK cells in splenocytes. The arrows indicate
NK cells located in the area of splenic pulp, where the membrane
surfaces of NK cells are stained brown with GM1 antibody
counterstained with hematoxylin. Original magnification  400.
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Renal structural injury
The renal structural injury induced by ADR was consistent
with our previous studies.2 In particular, there was a
reduction in tubular cell height, and an increase in tubular
luminal diameter, glomerulosclerosis, and interstitial
volume in comparison to control (Figure 4, Table 2).
However, there was no effect of NK depletion with
anti-asialo GM1 on any renal pathological parameter in
mice with AN (Table 2).
AN in SCID and NOD-SCID mice
In order to investigate further whether NK cells are involved
in the renal injury induced by ADR, SCID and NOD-SCID
mice were treated with a single low dose (6.5 mg/kg) injection
of ADR. Histological analysis demonstrated that ADR
induced severe renal injury in both T/B cell deficient mice
(SCID) and T/B cell plus NK cell deficient mice (Figure 5).
Morphometric analysis also demonstrated that ADR led to
similar renal injury in SCID or NOD-SCID mice (Table 3).
Furthermore, both SCID and NOD-SCID mice exposed to
low-dose ADR showed similar degrees of pathological injury
in glomeruli, tubules, and interstitium to BALB/c mice (with
intact T, B, and NK cells) treated with high-dose ADR with or
without anti-asialo GM1 (Figures 4 and 5 and Tables 2 and
3), indicating that immunodeficient mice (SCID and NOD-
SCID) are more sensitive to ADR than immunocompetent
mice.
NK activating receptor NKG2D and its ligand RAE-1 are
upregulated by AN
The NK cell activating receptor NKG2D and its ligand RAE-1
were upregulated in AN (Figure 6a). NKG2D is expressed
on a variety of cells including gd T cells, CD8 T cells,
NK cells, and macrophages. Baseline NKG2D expression
was higher in SCID mice than BALB/c mice (Po0.05)
consistent with higher levels of NK cells, but was not
altered by AN consistent with the histology showing
limited NK cell infiltration (Figure 6a). RAE-1 was
upregulated in both BALB/c and SCID mice with AN
analyzed by reverse transcriptase real-time PCR assay (Figure
6b), indicating increased level of the activation signal for NK
cells after ADR.
MHC Class I molecule expression is also upregulated by ADR
The MHC Class I molecule identified by anti-H2Kd using
flow cytometry was found expressed on non-haematopoietic
(CD45) renal cells in both BALB/c and SCID mice. ADR
significantly increased the level of MHC Class I molecule
expression on non-haematopoietic (CD45) renal cells in
both BALB/c and SCID mice (Figure 7).
Table 1 | Body weight and renal function of normal BALB/c
mice and BALB/c mice with AN treated or not with GM1
at 5 weeks
Normal
(n=6)
ADR
(n=7)
ADR/GM1
(n=7)
Body wt (g) 24.073.4 20.172.6 21.173.6
Serum creatinine (mmol/l) 22.079.9 31.677.4 28.775.4
Serum albumin (g/l) 25.271.8 22.473.8 24.872.1
Urine protein (mg/16 h) 1.0570.27 3.8870.72* 4.8670.63*
Urine creatinine (mmol/16 h) 2.2170.80 0.6070.19** 0.7670.16**
Creatinine clearance (ml/min) 42.2715.9 21.779.1* 15.274.5*
*Po0.05, **Po0.01 versus normal control.
ADR, adriamycin.
Normal ADR ADR/GM1
a b c
Figure 4 | Histology of kidney sections of normal and ADR BALB/c
mice treated or not with GM1. (a) Kidney of normal BALB/c mice.
(b) Kidney of BALB/c mice with AN. (c) Kidney of AN mice treated
with GM1. The results of morphometric analysis of the histological
changes are summarized in Table 2. Original magnification  400.
Table 2 | Morphometric analysis of BALB/c mice treated with
PBS (control), ADR or ADR and GM-1
Normal (n=6) ADR (n=7) ADR/GM1 (n=7)
Tubular diameter (mm) 28.370.4 30.970.3* 31.372.3*
Tubular cell height (mm) 10.470.2 8.970.5* 9.170.4*
Glomerulosclerosis (%) 0 14.875.2*** 11.372.2***
Interstitial volume (%) 7.570.6 47.171.9*** 41.672.0***
*Po0.05, ***Po0.001 versus normal control.
PBS, phosphate-buffered saline; ADR, adriamycin.
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Figure 5 | Histology of kidney sections of normal and ADR SCID
and NOD-SCID mice. (a) Kidney of normal SCID mice, (b) kidney of
normal NOD-SCID mice, (c) kidney of AN SCID mice, and (d) kidney
of AN NOD-SCID mice. The results of morphometric analysis of
the histological changes are summarized in Table 3. Original
magnification  400.
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DISCUSSION
Effector cells of the innate immune response play a crucial
role in initiating T cell activation.19–22 NK cells are capable of
rapid secretion of cytokines such as IFN-g, and may act as
effector cells.23–27 Our previous studies have demonstrated
the involvement of CD4þ and CD8þ T cells in the ADR
induced nephropathy in mice.6,7 Depletion of CD8þ T cells
protected against AN, suggesting CD8þ T cells are effectors
in this model of progressive chronic renal disease.6 The
worsening of disease in SCID mice suggested that NK cells
might be pathogenic either directly or through enhanced
activation of other effector cells. Whereas the number of NK
cells in kidney, analyzed by FACScan, was increased in AN
BALB/c mice compared to control, depletion of NK cells
from peripheral blood as well as ADR treated kidney had no
effect in wild-type mice. Moreover, in immunodeficient SCID
mice the additional functional impairment of NK cells (in
NOD-SCID) had no effect on disease.
Despite the expression of NK cell activating receptors on
NK cells and the expression and upregulation of its ligand
RAE-1 in the AN kidney, significant NK cell mediated
damage was not found in either the wild-type or immuno-
deficient mice. The enhanced NKG2D expression in wild-
type mice with AN is consistent with its expression on other
effector cells such as CD8 T cells, gd T cells, and
macrophages.28 The absence of enhancement of NKG2D
expression in the kidney in AN in immunodeficient mice
suggests that the populations expressing NKG2D are likely to
be CD8 or gd T cells, which are not present in the
immunodeficient mice, rather than macrophages which are
present and activated in both models of AN.
RAE-1 is a molecule upregulated by stress and is found
expressed in malignancy and infection. More recently, it has
been shown to be expressed in autoimmune disease, in the
pancreas of mouse models of diabetes where blockade of its
interaction with NKG2D limits disease.29 Similarly, its human
homologue has been shown to activate CD8 T cells in coeliac
disease.30 However, while it may play a role in activating
other immune cells in AN, it does not appear to activate the
NK cell subset.
NK cell activation is controlled by a precise balance
between inhibitory and activating signals. While inhibitory
signals had been the explanation of the ‘missing self ’
hypothesis of activation with identification of the inhibitory
Ly49 receptors, this has changed with the recognition of
activating receptors.31,32 Activation of NK cells can be
achieved when activation receptors are properly engaged by
specific ligands expressed on target cells and the inhibition by
MHC Class I molecule is missing or weak.31 Expression of the
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Figure 6 | NK cell activation receptor NKG2D (a) and its ligand
RAE-1 (b) expression by reverse transcriptase real-time PCR
assay in AN (n¼ 4 for each group). The results presented were
normalized against glyceraldehyde-3-phosphate dehydrogenase.
Data are means7s.d. *Po0.05, **Po0.02 (rank-sum test).
Ctr¼ control.
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Figure 7 | Flow cytometry analysis of MHC Class I molecule
expression by kidney tubular cells (n¼ 4 for each group). The
tubular H2Kd positive cells were analyzed by gating at CD45
population. Data are means7s.d. of each group. **Po0.01 (Student’s
t-test).
Table 3 | Morphometric analyses and renal function of SCID and NOD-SCID mice treated or not with ADR
SCID mice NOD-SCID mice
Normal (n=6) ADR (n=6) Normal (n=6) ADR (n=6)
Tubular diameter (mm) 30.671.4 34.771.3* 32.771.5 34.673.8
Tubular cell height (mm) 9.570.7 7.970.7* 9.870.2 8.670.1*
Glomerulosclerosis (%) 0 10.572.4*** 0 10.875.6***
Interstitial volume (%) 9.570.6 41.1714.5** 7.575.7 36.8716.7**
Urine protein (mg/16 h) 0.7470.32 3.2070.43*** 0.8770.27 3.2070.30***
Creatinine clearance (ml/min) 48.1713.4 35.5715.2 46.370.5 33.279.5*
*Po0.05, **Po0.01, ***Po0.001 versus normal. There were no difference between SCID ADR and NOD-SCID treated with ADR.
SCID-NOD, severe combined immunodeficient-nonobese diabetic.
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NKG2D ligand was found to induce antitumor activity even
to tumors expressing Class I MHC.33 A recent study
exploring the balance of inhibitory and activating signals
showed that the NKG2D receptor mediating NK cell
activation was regulated by inhibitory Ly49 receptors upon
recognition of MHC Class I molecules expressed on target
cells.34 An increased expression of the MHC Class I molecule
H-2kd is found in the AN kidney in keeping with an
inhibitory role in NK cell activation. Thus, we speculate that
the absence of NK cell activation through NKG2D by its
ligand RAE-1 could possibly be overridden by the inhibitory
signal of MHC Class I molecules expressed in AN. This
speculation could be confirmed by blocking the interaction
between increased MHC Class I molecules and their receptors
on NK cells. It also suggests that the greater severity of AN in
SCID mice is due to loss of protective or regulatory immune
responses and not because of enhanced NK cell mediated
damage. Thus, the absence of NK cell mediated injury in
SCID mice suggests a role for other cells in the innate system
such as macrophages and neutrophils. The success of AN
model in SCID and NOD-SCID mice suggested a pathogenic
role of macrophages. The pathogenic role of macrophage has
been confirmed in another study from our laboratory using
macrophage depletion.35
In conclusion, AN in wild-type and immunodeficient
mice demonstrates that NK cells do not play a significant role
in AN. An increased expression of NK inhibitory signals from
the Class I MHC molecules in diseased kidney in the presence
of NK activation signals NKG2D and RAE-1 might explain
why NK cells are not involved in mediating renal injury in
murine AN.
MATERIALS AND METHODS
Animals
BALB/c, SCID, and NOD-SCID mice were bred at the
Animal House of Westmead Hospital. All animals were maintained
under controlled conditions of light/dark exposure and constant
temperature/humidity. The experiments were performed in strict
accordance with protocols approved by the Animal Ethics
Committee of the University of Sydney and Western Sydney Area
Health Service.
Treatment of animals
Male mice, 7 to 8 weeks old and 20–25 g of body weight were
randomly distributed among experimental groups. Normal control
mice were treated with isotonic saline (n¼ 6). Adriamycin (ADR,
doxorubicin hydrochloride; Pharmacia & Upjohn Pty Ltd, Perth,
Australia) was administered by a single tail vein injection (n¼ 7).
GM1/ADR mice (n¼ 7) were pretreated with 40 ml/mouse of anti-
asialo-GM1 serum (GM1) in order to deplete NK cells, and then
36 h later 10 mg/kg of ADR was injected. Further, the same volume
of GM1 was injected every 5 days until mice were killed at week 5. In
another experiment, SCID mice (which lack functioning T and B
cells) and NOD-SCID mice (which lack functioning NK, T, and B
cells) were treated with a single low dose of ADR (6.5 mg/Kg)(n¼ 6)
or nothing (control) (n¼ 6). In these immunodeficient mice, a
lower dose of ADR was used to produce the same degree of injury as
in immunocompetent mice.
Assessment of NK cell depletion
NK cell levels were assessed by flow cytometric analysis of kidney
infiltrating cells and spleen cells from normal control (n¼ 4), ADR
(n¼ 5) and ADR/GM1 (n¼ 5) BALB/c mice. The kidney infiltrating
cells and splenocytes were prepared by LymphoprepTM (NYCOMED
PHARMA AS, Oslo, Norway). The kidney infiltrating cell suspen-
sion was made by mashing kidneys, which have been perfused with
warm saline to remove blood cells before collection, through a 70 mM
cell strainer (BD FalconTM, Bedford, MA, USA) with RPMI-1640.
The splenocyte suspension was made by mashing spleen between
two frosted glass plates and reconstituting in phosphate-buffered
saline. The cells were collected from the interface of gradient
centrifugation and washed three times with fluorescence-activated
cell-sorter staining buffer (Dulbecco’s phosphate-buffered saline
with 2% fetal calf serum/0.2% NaN3), and 10
6 cell aliquots were
incubated with Fc blocking anti-CD16/CD32 at 1 ml per 106 cells
diluted in 100ml staining buffer for 10 min on ice. Then the cells
were washed twice and stained with fluorescence in situ hibridiza-
tion-conjugated antibody for CD11a, PE-conjugated antibody for
NK cells (DX5), and PE-Cy5-conjugated antibody for mouse CD45,
incubated on ice for 30 min, then washed three times, resuspended
in staining buffer and analyzed by three-color flow cytometry using
a FACScan and Cell Quest software (Becton Dickinson, San Jose,
CA, USA). The cells were gated on CD45þ cells for analysis of
CD11aþ /DX5þ NK cells. Respective isotype controls: PE Rat IgM
isotype control, PE-Cy5 rat IgG2b isotype control, and fluorescence
in situ hibridization Rat IgG2a isotype control, were used for
determination of background fluorescence levels. An estimation of
number of NK cells in kidney was performed by multiplying the
total number of interstitial CD45þ cells by the percentage of NK
cells determined by FACS.
Sample collection and tissue preparation
At 34 days after ADR treatment (day 0), 16-h-urine was collected
using a metabolic cage on the day before killing, with access to water
only. Urinary volumes of all animals were recorded. At day 35, blood
samples were collected using cardiac puncture and the kidney and
spleen were harvested. Half of the organs were fixed in 10% neutral-
buffered formalin solution and embedded in paraffin, and the other
half were frozen using liquid nitrogen and stored at 801C.
Real time–polymerase chain reaction
Reverse transcription. Total RNA was extracted from kidneys
using Trizol (Gibco BRL, Drand Island, NY, USA) according to the
manufacturer’s recommendations. cDNA was synthesized by using
random hexamer primers (Promega, Madison, WI, USA) and a
M-MuLV reverse transcriptase kit (Gibco BRL, Drand Island, NY,
USA) following standard protocols.
Real-time PCR. Specific primers for mouse NKG2D (sense
50-caattcgattcacccttaacacatt-30; antisense, 50-gccacagtagcccctctcttgag-30)
and Taqman probe (FAM-tcagccagtattgtgc-MGB) and primers for
RAE-1 (sense 50-atgaattcttaaagcagtccaaggaa-30; antisense 50-ggaagtt
gatgtaagctgggtgata-30) and Taqman probe (FAM-agccaagatcaacctc-
MGB) were obtained from PE Applied Biosystems. Primers and a
probe for glyceraldehyde-3-phosphate dehydrogenase as a house
keeping gene control were used as previously described.36 cDNA was
amplified with specific primers in Universal Master Mix (PE Applied
Biosystems, Foster City, CA, USA) on an ABI 7700 instrument
(Applied Biosystems), according to the manufacturer’s instructions.
The cycling conditions for real-time were 501C for 2 min and 951C
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for 10 min, followed by 45 cycles of 951C for 15 s and 601C for
1 min. Data were analyzed using the Sequence Detector v1.9 Analysis
Software (Applied Biosystems).
MHC Class I molecule expression by flow cytometry
Cell suspension of kidney cortex was prepared by mashing through
70 mM cell strainer as described, followed by lysis of red cells, then
stained with PE-Cy5-conjugated antibody for mouse CD45 and
PE-conjugated anti-mouse H2kd for MHC Class I molecule, and
analyzed by two-color flow cytometry using a FACScan flow
cytometer and CellQuest software (Becton Dickinson, San Jose,
CA, USA). The cells were gated on CD45 negative population for
tubular H2kd expression, excluding dead cells by propidium iodide
(PI, BD) staining.
Histology
The methods for histochemistry were as described previously.2 In
brief, slides of sectioned kidney were stained with each of periodic
acid-Schiff, hematoxylin–eosin37 and Masson’s trichrome. Glomerulo-
sclerosis was evaluated in periodic acid-Schiff-stained sections, while
cellular infiltration of glomeruli and interstitium was assessed by
counting nuclei in hematoxylin–eosin-stained sections. Interstitial
fibrosis was assessed in sections stained with Masson’s trichrome.
Morphometric analysis
Renal morphology was analyzed using Optimas image analysis
system (Optimas Corporation, Seattle, WA, USA). Glomerular
surface area, glomerular capillary area, mesangial matrix area,
number of nuclei per glomerulus, interstitial volume, tubular
diameter, and tubule cell height was assessed as described
previously.2 Glomerulosclerosis was quantitated using the percen-
tage increase in relative mesangial matrix area (periodic acid-Schiff-
positive area within the glomerulus divided by the glomerular
capillary area, magnification  400),38 while the degree of
interstitial expansion was quantitated using the relative interstitial
volume on periodic acid-Schiff-stained sections. Tubular atrophy
was defined as the presence of dilated tubules with cellular
degeneration (low cell height and absence of brush border) and
thickened, wrinkled basement membrane. All mean values were
calculated from each of 20 glomeruli or tubules or 10 random
cortical regions per section, as described previously.2
Immunohistochemistry
Immunohistochemical analysis was performed using previously
described methods.2 In short, tissues were incubated in Tris-buffered
saline (0.8% Tris-HCl (Sigma) and 0.9% NaCl (Sigma), pH 7.6) for
5 min and incubated in blocking reagent (Tris-buffered salineþ 10%
(vol/vol) normal rabbit serum; Dako) for 15 min. Incubation with
relevant primary antibodies was carried out for 2 h at room
temperature. Control cryostat sections were incubated at the same
time with control antibody (normal rat immunoglobulin). After
rinsing twice in Tris-buffered saline for 5 min each, sections were
incubated with secondary antibodies for 30 min at room tempera-
ture. This was followed by rinsing in Tris-buffered saline and
incubation with ABC complex (Zymed Laboratories Inc., San
Francisco, CA, USA) for 30 min; 3,3-diaminobenzidine substrate-
chromogen solution (Dako) was applied for less than 5 min and
then washed thoroughly in distilled water. Slides were counter-
stained with hematoxylin (Sigma), dehydrated, and cover-slipped.
Positive immunoreactivity resulted in brown staining of the cell
membrane. Normal nuclei and cytoplasm were stained lightly. For
assessment of interstitial infiltration, positively stained interstitial
cells were counted from five random cortical fields (magnification
 400) in each section, and the numbers were averaged for each
field.
Renal function
Total urinary protein was quantitated using the Bio-Rad protein
assay kit (Bio-Rad Laboratories, Hercules, CA, USA). The
concentration of albumin and creatinine in plasma and urine were
determined in duplicate using a BM/Hitachi 747 analyzer (Tokyo,
Japan) at the Institute of Clinical Pathology and Medical Research,
Westmead Hospital. Renal function was assessed by creatinine
clearance (CCr) according to the clearance formula,
CCr¼ (UCrV)/PCr, where UCr is the concentration of creatinine
in urine, PCr is the concentration of creatinine in plasma, and V is
the urine flow rate in milliliters per minute.
Statistical analysis
Data are presented as mean7s.d. Data were compared using one-
way analysis of variance, followed by multiple pair-wise comparison
according to the Newman–Keuls test, Student’s t-test, and nonpara-
metric rank test. A P-value of o0.05 was considered significant.
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